BioSpace News Archive

Business

Prelude Therapeutics Rakes in $60 Million in Series B Funding, Expands Executive Team

The round brings total financing up to $95 million.

June 12, 2019
·
2 min read
·
Mark Terry
Global BioLife’s new mosquito repellent formula performs well against mosquitos in independent testing

Singapore Exchange-listed Singapore eDevelopment Limited wishes to announce that its U.S. biomedical subsidiary, Global BioLife Inc., has independently tested a new mosquito repellent formula which performs well against mosquitos for six to eight hours.

June 12, 2019
·
5 min read
Drug Development

BioSpace Global Roundup, June 13

Companies from across the globe share business and pipeline updates.

June 12, 2019
·
4 min read
·
Alex Keown
Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis

First-of-its-kind data shows efficacy and safety of a biologic in the management of axial manifestations of psoriatic arthritis (PsA), which affect up to an estimated 35 million people worldwide

June 12, 2019
·
9 min read
Business

Alexandria Real Estate Equities, Inc. Announces Strategic Partnership With Columbia University to Open Alexandria LaunchLabs @ Columbia, Deepening Its Focus on Cutting-Edge Life Science Companies Spinning Out of NYC’s Academic Institutions

Since the opening of Alexandria LaunchLabs at the Alexandria Center for Life Science – NYC in June 2017, its member companies have collectively raised more than $300 million in financing, with two of its companies completing IPOs

June 12, 2019
·
5 min read
Deals

ADC Therapeutics Announces Completion of a Series E Financing Expansion

Brings total raised in the Series E round to $276 million

June 12, 2019
·
3 min read
Business

ADC Therapeutics Announces Presentations at the 15th International Conference on Malignant Lymphoma

Pyrrolobenzodiazepine-based antibody drug conjugates demonstrate potential for the treatment of relapsed or refractory lymphomas as single agents and in combination therapies

June 12, 2019
·
6 min read
Job Trends

Neos Therapeutics to Present at Two Upcoming June Conferences

Neos Therapeutics, Inc. announced that Jerry McLaughlin, its Chief Executive Officer, will present a company overview at two upcoming conferences in June.

June 12, 2019
·
1 min read
Genetown

KnipBio Announces Significant Development in Lower-Cost Feedstock Solution for Aquafeed Protein

KnipBio, Inc. announced a major development in its fermentation research that enables the company to produce its single cell protein aquafeed ingredient, KnipBio Meal, from condensed distillers’ solubles.

June 12, 2019
·
2 min read
Cosentyx® provides long-lasting inhibition of radiographic progression in psoriatic arthritis, new Novartis data show

Novartis, announced new data from the FUTURE 5 trial showing no radiographic progression (mTSS <0.5) in almost 90% of psoriatic arthritis (PsA) patients treated with Cosentyx® (secukinumab) 300mg over 2 years.

June 12, 2019
·
9 min read